Kennichi C. Dowdell

发表

Varicella-Zoster Virus ORF12 Protein Triggers Phosphorylation of ERK1/2 and Inhibits Apoptosis

Xueqiao Liu, E. Fischer, Qingxue Li, 2012, Journal of Virology.

Late-Onset Severe Chronic Active EBV in a Patient for Five Years with Mutations in STXBP2 (MUNC18-2) and PRF1 (Perforin 1)

E. Jaffe, S. Pittaluga, H. Heslop, 2015, Journal of Clinical Immunology.

Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.

Kennichi C. Dowdell, J. Cohen, D. Knipe, 2009, The Journal of infectious diseases.

undefined autoimmune lymphoproliferative syndrome mutations are common in patients with genetically FAS Somatic

E. Jaffe, S. Pittaluga, J. Puck, 2012 .

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.

J. B. Oliveira, M. Raffeld, S. Pittaluga, 2011, Blood.

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.

J. B. Oliveira, Joie Davis, T. Fleisher, 2010, The Journal of allergy and clinical immunology.

Glutamine supplementation suppresses herpes simplex virus reactivation

T. Myers, Kennichi C. Dowdell, J. Cohen, 2017, The Journal of clinical investigation.

Valproic Acid (VPA), a Histone Deacetylase (HDAC) Inhibitor, Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Kennichi C. Dowdell, K. Steadman, S. Straus, 2006 .

Cutting Edge: Lymphoproliferation Caused by Fas Deficiency Is Dependent on the Transcription Factor Eomesodermin

D. Teachey, S. Grupp, A. Intlekofer, 2010, The Journal of Immunology.

Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes.

G. Hortin, T. Fleisher, A. Remaley, 2012, Clinical biochemistry.

Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr−/− mice or in patients with autoimmune lymphoproliferative syndrome

J. Puck, T. Fleisher, V. Hoffmann, 2007, American journal of hematology.

Ganetespib, an HSP90 inhibitor, kills Epstein–Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood

D. Proia, J. Trepel, Kennichi C. Dowdell, 2017, Leukemia & lymphoma.

NK Cells Regulate CD4 Responses Prior to Antigen Encounter1

Kennichi C. Dowdell, S. Stohlman, D. Cua, 2003, The Journal of Immunology.

Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic–pituitary–adrenal axis

Kennichi C. Dowdell, C. Whitacre, R. Wardrop, 1999, Journal of Neuroimmunology.

Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine.

Makinna Oestreich, P. Daugherty, Kennichi C. Dowdell, 2021, The Journal of infectious diseases.

Gender-Dependent IL-12 Secretion by APC Is Regulated by IL-101

Kennichi C. Dowdell, S. Stohlman, E. Kirkman, 2000, The Journal of Immunology.

Is Regulated by IL-10 Gender-Dependent IL-12 Secretion by APC and

Kennichi C. Dowdell, S. Stohlman, E. Kirkman, 2000 .

Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase

W. Wilson, J. Hughes, J. McElwee, 2019, Front. Immunol..

Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 Pathways

G. Uzel, Qingxue Li, Kennichi C. Dowdell, 2020 .

Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.

S. Pittaluga, S. Holland, A. Hsu, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome.

M. Raffeld, S. Pittaluga, G. Fahle, 2013, Blood.

Late-Onset Severe Chronic Active EBV in a Patient for Five Years with Mutations in STXBP2 (MUNC18-2) and PRF1 (Perforin 1)

E. Jaffe, S. Pittaluga, H. Heslop, 2015, Journal of Clinical Immunology.